-transparent.png){kind=logo}
The injection of murine interferon three times weekly in dose levels of 1,250, 5,000, or 20,000 U produced no significant antitumor effect against primary 239Pu-induced osteosarcomas in C57BL/6J mice. The interferon treatment was begun 94 days after the plutonium injection, which is well before the radiographic or microscopic appearance of neoplasia, and was continued until the moribund state or death. The average radiation dose accumulated by the skeleton at the time of first treatment was approximately 300 rad. The largest dose of interferon studied, 20,000 U/injection, was approximately 3 X 10(6) U/m2 of body surface, or 10(6) U/kg body weight.
Related Publications
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
January 1980,
Neoplasma,
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
October 1981,
Radiation research,
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
January 2010,
Journal of radiation research,
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
January 1967,
ANL,
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
August 1966,
Radiology,
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
January 1984,
Voprosy onkologii,
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
February 1976,
Laboratory animal science,
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
May 1970,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
March 1981,
Cancer research,
G N Taylor, and
E R Kern, and
B Braaten, and
L A Glasgow, and
M E Wrenn, and
D A Atherton, and
C W Mays, and
K Charrier, and
G Ayoroa
May 1995,
Cancer letters,
